Brevan Howard Capital Management’s Arcus Biosciences RCUS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$97.5K	Buy	+11,972	New	+$97.5K	﹤0.01%	1695
2025 Q1	–	Sell	-14,279	Closed	-$213K	–	1354
2024 Q4	$213K	Buy	14,279 +3,957	+38%	+$58.9K	﹤0.01%	862
2024 Q3	$158K	Sell	10,322 -20,641	-67%	-$316K	﹤0.01%	979
2024 Q2	$472K	Buy	+30,963	New	+$472K	﹤0.01%	579